Kivexa 600 mg/300 mg film-coated tablets clinical trials

Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA)

This study looks at how HIV medicines work in pregnant women. Researchers want to understand how the medicines are absorbed, used, and leave the body during and after pregnancy, and how they might affect babies. It's for women living with HIV who are pregnant or have recently given birth.